Picture of Aquestive Therapeutics logo

AQST Aquestive Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

U.S. RESEARCH ROUNDUP-Highpeak Energy, Nordstrom, Victoria'S Secret & Co

March 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,
including Highpeak Energy, Nordstrom and Victoria'S Secret & Co, on Thursday. 
     
    HIGHLIGHTS
    
                 * Highpeak Energy Inc  HPK.O : Gerdes Energy Research cuts to sell from buy
 
                 * Nordstrom Inc  JWN.N : Jefferies cuts to hold from buy
 
                 * Victoria'S Secret & Co  VSCO.N : JP Morgan cuts to underweight from neutral
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
   
                 * Abercrombie & Fitch Co  ANF.N : Jefferies raises target price to $155 from $149
 
                 * Abercrombie & Fitch Co  ANF.N : JP Morgan raises target price to $125 from $109
 
                 * Aquestive Therapeutics Inc  AQST.O : Wedbush raises target price to $9 from $4
 
                 * Astrana Health Inc  ASTH.O : Jefferies raises target price to $51 from $50
 
                 * Biohaven Ltd  BHVN.N : JP Morgan raises target price to $57 from $56
 
                 * Bridgebio pharma Inc  BBIO.O : Leerink Partners cuts target price to $57 from $59
 
                 * Brown-Forman Corp  BFb.N : RBC cuts target price to $56 from $60
 
                 * Campbell Soup Co  CPB.N : JP Morgan cuts target price to $45 from $48
 
                 * Cytokinetics Inc  CYTK.O : JP Morgan cuts target price to $77 from $78
 
                 * Dermtech Inc  DMTK.O : BTIG cuts target price to $2 from $4
 
                 * Elevation Oncology Inc  ELEV.O : Leerink Partners raises target price to $10 from $8
 
                 * European Wax Center Inc  EWCZ.O : Piper Sandler cuts target price to $18 from $20
 
                 * Foot Locker Inc  FL.N : Barclays cuts target price to $22 from $26
 
                 * Foot Locker Inc  FL.N : Jefferies cuts target price to $24 from $25
 
                 * Foot Locker Inc  FL.N : JP Morgan cuts target price to $23 from $26
 
                 * Foot Locker Inc  FL.N : Piper Sandler cuts target price to $31 from $37
 
                 * Highpeak Energy Inc  HPK.O : Gerdes Energy Research cuts target price by $8 to $12
 
                 * Highpeak Energy Inc  HPK.O : Gerdes Energy Research cuts to sell from buy
 
                 * Newtekone Inc  NEWT.O : Piper Sandler cuts target price to $13 from $14
 
                 * Nordstrom Inc  JWN.N : Jefferies cuts to hold from buy
 
                 * Nordstrom Inc  JWN.N : Jefferies cuts target price to $17 from $18
 
                 * Onespan Inc  OSPN.O : D.A. Davidson raises target price to $12 from $9.5
 
                 * Pacira Biosciences Inc  PCRX.O : JP Morgan assumes with overweight rating
 
                 * Pacira Biosciences Inc  PCRX.O : JP Morgan assumes with price target $45
 
                 * Tarsus Pharmaceuticals Inc  TARS.O : Jefferies raises target price to $44 from $30
 
                 * Triplepoint Venture Growth BDC Corp  TPVG.N : Piper Sandler cuts PT to $10 from $11
 
                 * United Natural Foods Inc  UNFI.N : Jefferies cuts target price to $13.5 from $15
 
                 * Viavi Solutions Inc  VIAV.O : Susquehanna raises target price to $14 from $12
 
                 * Victoria'S Secret & Co  VSCO.N : JP Morgan cuts target price to $15 from $22
 
                 * Victoria'S Secret & Co  VSCO.N : JP Morgan cuts to underweight from neutral
 
                 * Wesco International Inc  WCC.N : Oppenheimer raises target price to $190 from $175
 
                 * Zymeworks Inc  ZYME.O : Jefferies raises target price to $14 from $13
 
        
  

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Aquestive Therapeutics

See all news